Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor

Details for Australian Patent Application No. 2009307825 (hide)

Owner House Ear Institute Friedman, R. Vollrath, B.

Inventors Friedman, Rick; Vollrath, Benedikt

Agent Spruson & Ferguson

Pub. Number AU-A-2009307825

PCT Pub. Number WO2010/048095

Priority 61/107,615 22.10.08 US

Filing date 19 October 2009

Wipo publication date 29 April 2010

International Classifications

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 31/198 (2006.01)

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/4545 (2006.01)

A61P 27/16 (2006.01) Drugs for disorders of the senses

Event Publications

19 May 2011 Alteration of Name

  The name of the applicant has been altered to House Ear Institute; Friedman, R.; Vollrath, B.

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048095 Priority application(s): WO2010/048095

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307826-Intraocular lens injection systems and methods

2009307821-Boron crosslinkers for fracturing fluids with appreciably lower polymer loading and related methods and compositions